Corporate Portfolio Strategy

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 18 Experts worldwide ranked by ideXlab platform

Holger Patzelt - One of the best experts on this subject based on the ideXlab platform.

  • Corporate entrepreneurship managers project terminations integrating Portfolio level individual level and firm level effects
    Entrepreneurship Theory and Practice, 2016
    Co-Authors: Judith Behrens, Holger Patzelt
    Abstract:

    Corporate entrepreneurship managers often need to terminate projects to maximize their innovation Portfolios' commercial prospects. Drawing on the attention‐based view of the firm, we develop a model for how past project failure experience, the firm's growth rate, and their hierarchical level impact managers' attention to a project's fit with the Corporate Portfolio Strategy and the balance of the Portfolio when terminating projects. Using data from a conjoint study with 6,944 assessments of project terminations made by 217 managers, we provide insights into Corporate entrepreneurship decision making and how Portfolio‐level, individual‐level, and firm‐level aspects interact in explaining project termination.

Judith Behrens - One of the best experts on this subject based on the ideXlab platform.

  • Corporate entrepreneurship managers project terminations integrating Portfolio level individual level and firm level effects
    Entrepreneurship Theory and Practice, 2016
    Co-Authors: Judith Behrens, Holger Patzelt
    Abstract:

    Corporate entrepreneurship managers often need to terminate projects to maximize their innovation Portfolios' commercial prospects. Drawing on the attention‐based view of the firm, we develop a model for how past project failure experience, the firm's growth rate, and their hierarchical level impact managers' attention to a project's fit with the Corporate Portfolio Strategy and the balance of the Portfolio when terminating projects. Using data from a conjoint study with 6,944 assessments of project terminations made by 217 managers, we provide insights into Corporate entrepreneurship decision making and how Portfolio‐level, individual‐level, and firm‐level aspects interact in explaining project termination.

Ulrich Pidun - One of the best experts on this subject based on the ideXlab platform.

  • Corporate Portfolio Strategy
    Corporate Strategy, 2019
    Co-Authors: Ulrich Pidun
    Abstract:

    We are now in the central chapter of this book and can turn to the formulation of the Corporate Portfolio Strategy. It is arguably the most important element of Corporate Strategy, and many managers use the terms Portfolio Strategy and Corporate Strategy almost interchangeably. We have all ingredients together: agreement on the Corporate ambition, financial objectives, and guardrails for mission and vision (Chap. 2); a clear understanding of the Corporate capabilities on which the future Strategy can be built (Chap. 3); a candid evaluation of the existing strategic business units through different lenses and of the overall value-creation potential and balance of the Portfolio (Chap. 4); and a prioritized list of growth opportunities within and beyond the existing Portfolio (Chap. 5). Now we can combine all these ingredients to define the future Portfolio Strategy of the company.

  • Managing the Corporate Portfolio
    Corporate Strategy, 2019
    Co-Authors: Ulrich Pidun
    Abstract:

    In Chap. 6, we have established how the Portfolio and growth analyses can be used to derive a Corporate Portfolio Strategy. The Strategy defines the target composition of the Portfolio but also the roles that the strategic business units (SBUs) are supposed to play in the Portfolio. In this chapter we will explain how the Portfolio roles can be used to manage the Corporate Portfolio. We will address how strategic priorities, financial targets, and investment guidelines can be linked to the roles. We will introduce concepts and instruments for allocating capital to the SBUs and to individual investment projects. And we will address the notorious challenge of managing synergies in the Corporate Portfolio.

  • Transforming the Corporate Portfolio
    Corporate Strategy, 2019
    Co-Authors: Ulrich Pidun
    Abstract:

    In Chap. 6, we have established how the Portfolio and growth analyses can be used to derive a Corporate Portfolio Strategy and in particular the target configuration of the Portfolio. In many cases, reaching this target Portfolio will require the divestiture of individual existing businesses and the growth into new businesses. We have already introduced acquisitions and alliances as two basic pathways of growth, as well as their specific advantages and disadvantages (Sect. 5.2). In the current chapter, we will give an overview of the process of conducting such Corporate transactions. We will introduce different deal types and provide empirical evidence on the chances of value creation. Based on our experience and the literature, we will present the key success factors for improving the odds of successful transactions and for the transformation of the Corporate Portfolio.

Margarethe F Wiersema - One of the best experts on this subject based on the ideXlab platform.

  • the measurement of Corporate Portfolio Strategy analysis of the content validity of related diversification indexes
    Southern Medical Journal, 2003
    Co-Authors: James Arthur Robins, Margarethe F Wiersema
    Abstract:

    Measures developed for the analysis of Corporate diversification have become fundamental to a broad range of Strategy research. This paper examines the content validity of the two most widely used continuous measures of related diversification—the related component of the entropy index and the concentric index—and raises fundamental questions about their validity as indicators of Portfolio relatedness. These questions are not driven by the use of SIC data for estimation of the indexes; they involve validity problems intrinsic to the construction of the measures. The related component of entropy and the concentric index are sensitive to features of Corporate Portfolio composition that may not be directly linked to Portfolio relatedness. These sensitivities can create important ambiguities in Strategy research. Copyright © 2002 John Wiley & Sons, Ltd.

James Arthur Robins - One of the best experts on this subject based on the ideXlab platform.

  • the measurement of Corporate Portfolio Strategy analysis of the content validity of related diversification indexes
    Southern Medical Journal, 2003
    Co-Authors: James Arthur Robins, Margarethe F Wiersema
    Abstract:

    Measures developed for the analysis of Corporate diversification have become fundamental to a broad range of Strategy research. This paper examines the content validity of the two most widely used continuous measures of related diversification—the related component of the entropy index and the concentric index—and raises fundamental questions about their validity as indicators of Portfolio relatedness. These questions are not driven by the use of SIC data for estimation of the indexes; they involve validity problems intrinsic to the construction of the measures. The related component of entropy and the concentric index are sensitive to features of Corporate Portfolio composition that may not be directly linked to Portfolio relatedness. These sensitivities can create important ambiguities in Strategy research. Copyright © 2002 John Wiley & Sons, Ltd.